Skip to main content
TipRanks
Go Ultimate75% OFF

Patrick D Campling Insider Profile

4 Followers

Patrick D Campling, Director at BriaCell Therapeutics, holds 0.00 shares in BriaCell Therapeutics (Ticker: TSE:BCT). Most recently, Patrick D Campling Sold 160,000 shares of BriaCell Therapeutics on Jul 05, 2012 for an estimated value of ―.

Patrick D Campling's Trading History

BCT
BriaCell Therapeutics
Jul 05, 2012DirectorInformative Sell―C$0.00
TSE:BCT
Insider Shares: 0.00 (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 05, 2012Informative SellC$0.00160,000C$0.00――
Jun 28, 2012Informative SellC$0.00210,000C$0.00――
Apr 28, 2011Uninformative SellC$24.00K200,000C$0.12――
Dec 10, 2010Informative SellC$0.00210,000C$0.00――
May 21, 2010Informative SellC$0.00105,000C$0.00――

You May Also Like

Patrick D Campling insider profile FAQ

What is the percentage of profitable transactions made by Patrick D Campling?
The percentage of profitable transactions made by Patrick D Campling is 86%.
What is the average return per transaction made by Patrick D Campling?
The average return per transaction made by Patrick D Campling is 26.10%.
What stocks does Patrick D Campling hold?
Patrick D Campling holds: TSE:BCT stocks.
What is Patrick D Campling's role in BriaCell Therapeutics?
Patrick D Campling's role in BriaCell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.